Table 1 Experimental groups
Group | Mice | Treatment | Duration (weeks) |
|---|---|---|---|
A | C57BL/6 | Vehicle | 8 |
B | C57BL/6 | Dexamethasone | 8 |
C | C57BL/6 | Dexamethasone + β-glucosylceramide | 8 |
D | C57BL/6 | Vehicle | 12 |
E | C57BL/6 | Dexamethasone | 12 |
F | C57BL/6 | β-glucosylceramide | 12 |
G | C57BL/6 | Dexamethasone for six weeks followed by Dexamethasone + β-glucosylceramide additional two weeks | Six weeks for induction and two weeks for treatment |
H | CD1d-/- | Vehicle | 8 |
I | CD1d-/- | Dexamethasone | 8 |
J | CD1d-/- | Dexamethasone + β-glucosylceramide | 8 |